DR. JOSEPH C WU, MD
Osteopathic Medicine in Palo Alto, CA
License number
California A066551
Category
Osteopathic Medicine
Type
Internal Medicine
License number
California A066551
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
2
300 Pasteur Dr Edwards BUILDING R354, Palo Alto, CA 94305
174 Louise Ln, San Mateo, CA 94403
174 Louise Ln, San Mateo, CA 94403
Phone
(650) 736-2246
(650) 736-0234 (Fax)
(650) 736-0234 (Fax)
Professional information
Joseph Chong-Sang Wu, Stanford CA
Specialties:
Psychiatry, Internal Medicine, Cardiovascular Disease
Work:
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford, CA 94305
300 Pasteur Dr, Stanford, CA 94305
Education:
University of California at Irvine (1982)
Double-Fusion Human Embryonic Stem Cells, Methods Of Making Double-Fusion Human Embryonic Stem Cells, Triple-Fusion Human Embryonic Stem Cells, Methods Of Making Triple-Fusion Human Embryonic Stem Cells, And Methods Of Monitoring Double-Fusion Human Embryonic Stem Cells And Triple-Fusion Human Embryonic Stem Cells
US Patent:
2009017, Jul 9, 2009
Filed:
Dec 4, 2008
Appl. No.:
12/315873
Inventors:
Joseph Ching-Ming Wu - Palo Alto CA, US
Feng Cao - San Jose CA, US
Feng Cao - San Jose CA, US
International Classification:
C12Q 1/66, C12N 5/10, C12N 15/09
US Classification:
435 8, 435346, 435455
Abstract:
Embodiments of the present disclosure include double-fusion human embryonic stem cells, methods of imaging double-fusion human embryonic stem cells, double-fusion polynucleotides, double-fusion proteins, triple-fusion human embryonic stem cells, methods of imaging triple-fusion human embryonic stem cells, triple-fusion polynucleotides, triple-fusion proteins, methods of monitoring the progression of human embryonic stem cells, methods of making isolated double-fusion human embryonic stem cells, methods of making isolated triple-fusion human embryonic stem cells, and the like.
Double-Fusion Human Embryonic Stem Cells, Method Of Making Double-Fusion Human Embryonic Stem Cells, Triple-Fusion Human Embryonic Stem Cells, Method Of Making Triple-Fusion Human Embryonic Stem Cells, And Methods Of Monitoring Double-Fusion Human Embryonic Stem Cells And Triple-Fusion Human Embryonic Stem Cells
US Patent:
2012014, Jun 7, 2012
Filed:
Jan 26, 2012
Appl. No.:
13/358838
Inventors:
Joseph Ching-Ming Wu - Palo Alto CA, US
Feng Cao - San Jose CA, US
Sanjiv Sam Gambhir - Porollo Valley CA, US
Feng Cao - San Jose CA, US
Sanjiv Sam Gambhir - Porollo Valley CA, US
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:
A61K 49/00, G01N 21/76, A61K 51/02, G01N 21/64
US Classification:
800 3, 435 618, 424 111, 424 96
Abstract:
Embodiments of the present disclosure include double-fusion human embryonic stem cells, methods of imaging double-fusion human embryonic stem cells, double-fusion polynucleotides, double-fusion proteins, triple-fusion human embryonic stem cells, methods of imaging triple-fusion human embryonic stem cells, triple-fusion polynucleotides, triple-fusion proteins, methods of monitoring the progression of human embryonic stem cells, methods of making isolated double-fusion human embryonic stem cells, methods of making isolated triple-fusion human embryonic stem cells, and the like.
Cardiomyocytes From Induced Pluripotent Stem Cells From Patients And Methods Of Use Thereof
US Patent:
2013002, Jan 31, 2013
Filed:
Jul 20, 2012
Appl. No.:
13/554946
Inventors:
Ning Sun - Stanford CA, US
Michael T. Longaker - Stanford CA, US
Robert C. Robbins - Stanford CA, US
Joseph Wu - Stanford CA, US
Feng Lan - Menlo Park CA, US
Andrew Stephen Lee - Palo Alto CA, US
Paul W. Burridge - Stanford CA, US
Michael T. Longaker - Stanford CA, US
Robert C. Robbins - Stanford CA, US
Joseph Wu - Stanford CA, US
Feng Lan - Menlo Park CA, US
Andrew Stephen Lee - Palo Alto CA, US
Paul W. Burridge - Stanford CA, US
International Classification:
C12Q 1/02, G01N 27/49, C40B 30/06, C12N 5/077, C40B 30/04, C40B 40/02, G01N 21/64, C12Q 1/68
US Classification:
506 9, 435 29, 435 612, 435366, 435 71, 435 611, 506 14, 506 10
Abstract:
Human somatic cells obtained from individuals with a genetic heart condition are reprogrammed to become induced pluripotent stem cells (iPS cells), and differentiated into cardiomyocytes for use in analysis, screening programs, and the like.
Use On Minicircle Vectors For Cardiac Gene Therapy
US Patent:
8445454, May 21, 2013
Filed:
Oct 22, 2010
Appl. No.:
12/925483
Inventors:
Joseph Wu - Palo Alto CA, US
Mark A. Kay - Los Altos CA, US
Mei Huang - Menlo Park CA, US
Zhi-Ying Chen - Foster City CA, US
Mark A. Kay - Los Altos CA, US
Mei Huang - Menlo Park CA, US
Zhi-Ying Chen - Foster City CA, US
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:
A61K 48/00, C07H 21/04, C07H 21/02, C12N 15/63
US Classification:
514 44, 536 231, 536 2431, 536 2433, 536 245, 4353201
Abstract:
Compositions and methods are provided for the treatment of an ischemic cardiovascular condition by providing a patient with a novel non-viral minicircle DNA vector comprising polynucleotide sequences that potentiate HIF-1 activity, including RNAi or antisense agents selective for proteins involved in HIF1 inactivation.
Enhanced Efficiency Of Induced Pluripotent Stem Cell Generation
US Patent:
2011024, Oct 6, 2011
Filed:
Feb 1, 2011
Appl. No.:
12/931476
Inventors:
Joseph Wu - Palo Alto CA, US
Michael T. Longaker - Stanford CA, US
Mark A. Kay - Stanford CA, US
Ning Sung - Stanford CA, US
FangJun Jia - Stanford CA, US
Zhi-Ying Chen - Shenzhen, CN
Nicholas Panetta - Pittsburg PA, US
Deepak Gupta - Stanford CA, US
Michael T. Longaker - Stanford CA, US
Mark A. Kay - Stanford CA, US
Ning Sung - Stanford CA, US
FangJun Jia - Stanford CA, US
Zhi-Ying Chen - Shenzhen, CN
Nicholas Panetta - Pittsburg PA, US
Deepak Gupta - Stanford CA, US
International Classification:
C12N 5/074, C12N 15/63
US Classification:
435366, 435377, 4353201
Abstract:
Human somatic cells are reprogrammed to become induced pluripotent stem cells (iPS cells) by the introduction of a minicircle DNA vector. Cells of interest include adipose stem cells.
Prevention Of Immunological Rejection Of Transplanted Stem Cells By Leukocyte Costimulatory Molecule Blockade
US Patent:
2011029, Dec 1, 2011
Filed:
May 16, 2011
Appl. No.:
13/068643
Inventors:
Jeremy Pearl - San Francisco CA, US
Joseph Wu - Stanford CA, US
Mark Davis - Atherton CA, US
Joseph Wu - Stanford CA, US
Mark Davis - Atherton CA, US
International Classification:
A61K 39/395, A61P 37/06, A61P 25/00, A61K 35/12, A61K 35/30
US Classification:
4241341, 424 937, 4241731
Abstract:
Compositions and methods are provided for transplantation of pluripotent stem cells and differentiated cells derived therefrom.
Novel Shrna Gene Therapy For Treatment Of Ischemic Heart Disease
US Patent:
2012000, Jan 5, 2012
Filed:
Sep 15, 2009
Appl. No.:
12/998075
Inventors:
Joseph C. Wu - Palo Alto CA, US
Amato John Giaccia - Stanford CA, US
Mei Huang - Palo Alto CA, US
Denise A. Chan - Palo Alto CA, US
Amato John Giaccia - Stanford CA, US
Mei Huang - Palo Alto CA, US
Denise A. Chan - Palo Alto CA, US
Assignee:
The Board of Trustees of the Leland Stanford Junio - Palo Alto CA
International Classification:
A61K 31/7105, A61P 17/02, A61P 7/00, C12N 15/85, A61P 9/10
US Classification:
514 44 R, 4353201
Abstract:
Short hairpin RNA (shRNA) interference therapy targeting hypoxia inducible factor—lot (HIF-1 α) prolyl-4-hydroxylase protein (HIF-PHD2) is used for treatment of myocardial ischemia. This treatment can be followed noninvasively by molecular imaging. Provided are compositions comprising novel vectors encoding shRNA targeting the HIF-1α and asparaginyl hydroxylase genes. The vectors encoding shRNA are also useful for the treatment of cardiac diseases, peripheral vascular diseases and decubitis ulcers.